(NASDAQ:PCRX) SASKATOON, Saskatchewan, Sept. 03, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (âPharmaCorpâ or the âCorporationâ) (TSXV: PCRX) is pleased to announce that it has entered into definitive share purchase agreements, each dated August 29, 2025 (the âAgreementsâ), to acquire from the same armâs length vendors (the âVendorsâ) a 100% interest in two PharmaChoice Canada bannered pharmacies located in Western Canada, one of which includes the associated lands and building (the âAcquisitionsâ).
Related Questions
How will the acquisition be financed and what dilution impact will it have on existing shareholders?
What revenue and cost synergies are expected from the two pharmacy acquisitions, and how will they affect PCRX's earnings guidance?
How does this expansion compare to recent moves by competing pharmacy chains in Canada, and what implications does it have for PCRX's market share and stock valuation?